pf-06427878
Small moleculeexperimental
Clinical trial activity
5 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
5
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Aug 1, 2014 (NCT02208284)
Timeline
2010s
- Jan 1, 2014
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Diacylglycerol O-acyltransferase 2INHIBITOR
DGAT2 inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- pf-06427878
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02855177 | Phase 1 | Aug 24, 2016 | Pfizer |
| NCT02410525 | Phase 1 | May 1, 2015 | Pfizer |
| NCT02391623 | Phase 1 | Mar 1, 2015 | Pfizer |
| NCT02237742 | Phase 1 | Nov 1, 2014 | Pfizer |
| NCT02208284 | Phase 1 | Aug 1, 2014 | Pfizer |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Pfizer | For profit | 5 | 5 | 1 | 2014 |
1 organizations
Page 1 / 1